Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor

Journal of Experimental Medicine

Volumn 190, Issue 6, 1999, Pages 875-880

  Kitamura, Takayuki ^a   Tanaka, Naohiko ^a,b   Watanabe, Junichi ^a   Uchida, Kanji ^a   Kanegasaki, Shiro ^a   Yamada, Yoshitsugu ^a   Nakata, Koh ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alveolar macrophage; Autoantibody; Granulocyte macrophage colony stimulating factor; Pulmonary alveolar proteinosis; Surfactant protein

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G ANTIBODY; NEUTRALIZING ANTIBODY;

ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; LUNG ALVEOLUS MACROPHAGE; LUNG ALVEOLUS PROTEINOSIS; LUNG LAVAGE; PRIORITY JOURNAL;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOGLOBULIN G; PULMONARY ALVEOLAR PROTEINOSIS;

EID: 0033588819     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.6.875     Document Type: Article

References (25)

1. van Golde, L.M.G., J.J. Batenburg, and B. Robertson. 1988. The pulmonary surfactant system: biochemical aspect and functional significance. Physiol. Rev. 68:374-455.
2. Kuroki, Y., and D.R. Voelker. 1994. Pulmonary surfactant protein. J. Biol. Chem. 269:25943-25946.
3. Prakash, U.B., S.S. Barham, H.A. Carpenter, D.E. Dines, and H.M. Marsh. 1987. Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review. Mayo Clin. Proc. 62:499-518.
4. Ramirez, R.J. 1971. Alveolar proteinosis: importance of pulmonary lavage. Am. Rev. Respir. Dis. 103:666-678.
5. Alberti, A., M. Luisetti, A. Braschi, G. Rodi, G. Iotti, D. Sella, V. Poletti, V. Benori, and A. Baritussio. 1996. Bronchoalveolar lavage fluids composition in alveolar proteinosis. Early changes after therapeutic lavage. Am. J. Respir. Crit. Care Med. 154:817-820.
6. Honda, Y., H. Takahashi, N. Shijubo, Y. Kuroki, and T. Akino. 1993. Surfactant protein-A concentration in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis. Chest. 103:496-499.
7. Bates, S.R., and A.B. Fosfer. 1996. Surfactant protein A is degraded by alveolar macrophages. Am. J. Physiol. 271: L258-266.
8. Dirksen, U., R. Nishinakamura, P. Groneck, U. Hattenhorst, L. Nogee, R. Murray, and S. Burdach. 1997. Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common β chain expression. J. Clin. Invest. 100:2211-2217.
9. Dranoff, G., A.D. Crawford, M. Sadelain, B. Ream, A. Rashid, R.T. Bronson, G.R. Dickersin, C.J. Bachurski, E.L. Mark, J.A. Whitsett, et al. 1994. Involvement of granulocyte-macrophage colony stimulating factor in pulmonary homeostasis. Science. 264:713-716.
10. Nishinakamura, R., N. Nakayama, Y. Hirabayashi, T. Inoue, D. Aud, T. McNeil, S. Azuma, S. Yoshida, Y. Toyoda, and K. Arai. 1995. Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL-3 receptor-deficient mice are normal. Immunity. 2:211-222.
11. Tanaka, N., J. Watanabe, T. Kitamura, Y. Yamada, S. Kanegasaki, and K. Nakata. 1999. Lungs of patients with idiopathic pulmonary alveolar proteinosis express a factor which neutralizes granulocyte-macrophage colony stimulating factor. FEBS Lett. 442:246-250.
12. Kitamura, T., T. Tange, T. Terasawa, S. Chiba, T. Kuwaki, K. Miyagawa, Y.F. Piao, K. Miyazono, A. Urabe, and F. Takaku. 1989. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J. Cell. Physiol 140:323-334.
13. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immimol. Methods. 65:55-57.
14. Golde, D.W., M. Territo, T.N. Finley, and M.J. Cline. 1976. Defective lung macrophages in pulmonary alveolar proteinosis. Ann. Intern. Med. 85:304-309.
15. Nugent, K.M., and E.L. Pesanti. 1983. Macrophage function in pulmonary alveolar proteinosis. Am. Rev. Respir. Dis. 127: 780-781.
16. Nishinakamura, R., R. Wiler, U. Dirksen, Y. Morikawa, K. Arai, A. Miyajima, S. Burdach, and R. Murray. 1996. The pulmonary alveolar proteinosis in granulocyte macrophage colony-stimulating factor/interleukins 3/5 βc receptor-deficient mice is reversed by bone marrow transplantation. J. Exp. Med. 183:2657-2662.
17. Huffman, J.A., W.M. Hull, G. Dranoff, R.C. Mulligan, and J.A. Whitsett. 1996. Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice. J. Clin. Invest. 97:649-655.
18. Gallay, P., J.-P. Mach, and S. Carrel. 1991. Characterization and detection of naturally occurring antibodies against IL-1α and IL-1β in normal human plasma. Eur. Cytokine Netw. 2:329-338.
19. Tiberio, L., A. Caruso, A. Pozzi, L. Rivoltini, D. Morelli, E. Monti, and A. Balsari. 1993. The detection and biological activity of human antibodies to IL-2 in normal donors. Scand. J. Immunol. 38:472-476.
20. Amiral, J., A. Marfaing-Koka, M. Wolf, M.C. Alessi, B. Tardy, C. Boyer-Neumann, A.M. Vissac, E. Fressinaud, M. Poncz, and D. Meyer. 1996. Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia. Blood. 88:410-416.
21. Sioud, M., A. Dybwad, L. Jespersen, S. Suleyman, J.B. Natvig, and O. Forre. 1994. Characterization of naturally occurring autoantibodies against tumor necrosis factor-alpha (TNF-α): in vitro function and precise epitope mapping by phage epitope library. Clin. Exp. Immunol. 98:520-525.
22. Svenson, M., M.B. Hansen, C. Ross, M. Diamant, K. Rieneck, H. Nielsen, and K. Bendtzen. 1998. Antibody to granulocyte-macrophage colony-stimulating factor is a dominant anti-cytokine activity in human IgG preparations. Blood. 91: 2054-2061.
23. Ragnhammar, P., H.J. Friesen, J.E. Frodin, A.K. Lefvert, M. Hassan, A. Osterborg, and H. Mellstedt. 1994. Induction of anti-recombinant human granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived) antibodies and clinical effects in nonimmunocompromised patients. Blood. 84:4078-4087.
24. Seymour, J.F., C.G. Begley, U. Dirksen, J.J. Presneil, N.A. Nicola, P.E. Moore, O.D. Schoch, P. van Asperen, B. Roth, S. Burdach, et al. 1998. Attenuated hematopoietic response to granulocyte-macrophage colony stimulating factor in patients with acquired pulmonary alveolar proteinosis. Blood. 92:2657-2667.
25. Goldstein, L.S., M.S. Kavuru, P. Curtis-McCarthy, H.A. Christie, C. Farver, and J.K. Stoller. 1998. Pulmonary alveolar proteinosis: clinical features and outcomes. Chest. 114: 1357-1362.